Departments of Obstetrics & Gynecology.
Pathology.
Am J Clin Oncol. 2021 Apr 1;44(4):162-168. doi: 10.1097/COC.0000000000000798.
Invasive pattern of endocervical adenocarcinomas (EACs) is known to influence lymph node metastasis and cancer recurrence. In this study we describe the prognostic significance of necrotic tumor debris (NTD) and tumor nuclear grade on recurrence risk stratification of early-stage cervical adenocarcinoma.
Patients who underwent surgery from 2007 to 2018 for International Federation of Gynecology and Obstetrics (FIGO) stage IA1-IB2 EAC, for whom pathology was available for review were included in this study. Clinico-pathologic variables and clinical recurrence risk stratification (low, intermediate, or high risk) were correlated to intraluminal NTD and tumor nuclear grade (N3).
Among 50 patients meeting inclusion criteria, all were managed surgically and clinically risk stratified as low (n=33), intermediate (n=13), and high risk (n=4). Twenty-three patients (46%) were NTD-N3 negative and 27 (54%) were NTD-N3 positive. NTD-N3 was significantly associated with higher stage, tumor grade, larger tumor size, positive lymphovascular space invasion, and recurrence of disease (P=0.025). Patients with stage IB1 EAC who were stratified as intermediate or high-risk for recurrence were positive for NTD-N3. Lack of NTD-N3 had 100% negative predictive value for disease recurrence.
NTD-N3, a novel pathologic finding, may be used to further stratify overall recurrence risk, and may play a role in individualization of patient care in early-stage EAC.
已知宫颈内膜腺癌(EAC)的侵袭模式会影响淋巴结转移和癌症复发。本研究旨在描述坏死肿瘤碎片(NTD)和肿瘤核分级对早期宫颈腺癌复发风险分层的预后意义。
本研究纳入了 2007 年至 2018 年期间因国际妇产科联盟(FIGO)分期 IA1-IB2 EAC 接受手术且有病理学检查结果可供评估的患者。分析临床病理变量与腔内 NTD 和肿瘤核分级(N3)与临床复发风险分层(低危、中危或高危)的相关性。
在符合纳入标准的 50 例患者中,所有患者均接受了手术治疗,并根据临床风险进行了分层,低危(n=33)、中危(n=13)和高危(n=4)。23 例(46%)患者的 NTD-N3 为阴性,27 例(54%)为阳性。NTD-N3 与较高的分期、肿瘤分级、较大的肿瘤大小、淋巴血管间隙浸润阳性和疾病复发显著相关(P=0.025)。IB1 期 EAC 患者被归类为中危或高危复发患者,NTD-N3 阳性。缺乏 NTD-N3 时,疾病复发的阴性预测值为 100%。
NTD-N3 是一种新的病理发现,可能用于进一步分层总体复发风险,并可能在早期 EAC 中为患者个体化治疗发挥作用。